Impact of Natalizumab Versus Fingolimod in Relapsing-Remitting Multiple Sclerosis (RRMS) Participants

Research Site, Camperdown

Research Site, New Lambton Heights

Research Site, Heidelberg

Research Site, Girona

Research Site, Stockholm

Research Site, Philadelphia

Research Site, Madrid

Research Site, Málaga

Research Site, Nîmes

Research Site, El Palmar

Research Site, Atlanta

Research Site, Toulouse

Research Site, Libourne

Research Site, Port Charlotte

Research Site, Vigo

Research Site, Knoxville

Research Site, Santa Cruz de Tenerife

Research Site, Gothenburg

Research Site, Des Moines

Research Site, Milwaukee

Research Site, Jihlava

Research Site, Erbach im Odenwald

Research Site, San Antonio

Research Site, Round Rock

Research Site, Freiburg im Breisgau

Research Site, Aurora

Research Site, Colorado Springs

Research Site, Seattle

Research Site, Tacoma

Research Site, Brno

Research Site, Brno

Research Site, Hradec Králové

Research Site, Ostrava - Poruba

Research Site, Pardubice

Research Site, Prague

Research Site, Teplice

Research Site, Gianicolense

Research Site, Roma

Research Site, Barcelona

Research Site, Seville

Research Site, London

Research Site, Glasgow